The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-hydroxy-N'-(3-hydroxybenzylidene)benzohydrazide ID: ALA4086936
PubChem CID: 6911452
Max Phase: Preclinical
Molecular Formula: C14H12N2O3
Molecular Weight: 256.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N/N=C/c1cccc(O)c1)c1cccc(O)c1
Standard InChI: InChI=1S/C14H12N2O3/c17-12-5-1-3-10(7-12)9-15-16-14(19)11-4-2-6-13(18)8-11/h1-9,17-18H,(H,16,19)/b15-9+
Standard InChI Key: HUTIWZPQDUIHEG-OQLLNIDSSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
20.1229 -2.8684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1177 -3.6879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8242 -4.1025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5324 -3.6946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5337 -2.8719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8307 -2.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2428 -4.1098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2399 -4.9311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9560 -3.6995 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6664 -4.1147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3797 -3.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0901 -4.1196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0838 -4.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7934 -5.3523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5076 -4.9461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5079 -4.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7977 -3.7092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4034 -4.0965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7902 -6.1736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
2 18 1 0
14 19 1 0
M END Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 256.26Molecular Weight (Monoisotopic): 256.0848AlogP: 1.86#Rotatable Bonds: 3Polar Surface Area: 81.92Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.62CX Basic pKa: 1.28CX LogP: 2.36CX LogD: 2.33Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.58Np Likeness Score: -1.10
References 1. Dutra LA, Guanaes JFO, Johmann N, Lopes Pires ME, Chin CM, Marcondes S, Dos Santos JL.. (2017) Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties., 27 (11): [PMID:28400236 ] [10.1016/j.bmcl.2017.04.007 ]